Pfizer's ex-chair and chief executive Ian Read and Frank D'Amelio – previously the drugmaker's finance chief – have issued a ...
Fresh record closes in the S&P and Dow might have been buoyed by a dovish Fed. But risks, like oil prices and increasing ...
Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034 ...